Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1404-19-9

Post Buying Request

1404-19-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1404-19-9 Usage

Description

Oligomycin is a macrolide antibiotic that consists of a mixture of A, B, and C isomers. It is a specific inhibitor of the mitochondrial ATP-synthase, which plays a crucial role in cellular energy production. Oligomycin inhibits membrane-bound mitochondrial ATP synthase, preventing the transfer of phosphoryl groups. This action leads to a decrease in cellular ATP levels, induction of autophagy, stimulation of lysosome acidification, and protection against ischemic kidney injury in male rats. It is a white to pale yellow powder in appearance.

Uses

1. Used in Pharmaceutical Industry:
Oligomycin is used as a specific inhibitor for mitochondrial ATP-synthase for research purposes. It helps in understanding the role of ATP synthase in cellular energy production and its potential as a target for therapeutic intervention.
2. Used in Cellular Research:
Oligomycin is used as a tool to decrease cellular ATP levels, which can be useful in studying the effects of reduced ATP on cellular processes and metabolism.
3. Used in Autophagy Studies:
Oligomycin is used to induce autophagy, a cellular process that involves the degradation and recycling of cellular components. This application is valuable for understanding the role of autophagy in various diseases and conditions.
4. Used in Lysosome Function Research:
Oligomycin is used to stimulate lysosome acidification, which can help researchers study the function and regulation of lysosomes in cellular processes.
5. Used in Kidney Protection Studies:
Oligomycin is used in research to protect against ischemic kidney injury in male rats, which can provide insights into potential therapeutic applications for kidney diseases and conditions.

Biochem/physiol Actions

Product does not compete with ATP.

in vitro

in a549, h1299, h1975, h520, 786-0, h838, and u87mg cancer cell lines, 100 ng/ml oligomycin could completely inhibit oxphos phosphorylation activity and stimulate various levels of glycolysis gains [1]. besides, 5 μg/ml oligomycin could inhibit the f0 part of h+-atp-synthase, and strongly suppress cytochrome c release and apoptosis in hela cells induced by tnf [2]. furthermore, oligomycin could inhibit mitochondrial respiration, and sensitize melanoma cells to cisplatin treatment to inhibit cell invasion [3].

Enzyme inhibitor

These macrolide antibiotics from Streptomyces diastatochromogenes have three major members: Oligomycin A (FW = 791.08 g/mol; CAS 14104-19- 9), Oligomycin B (FW = 805.06 g/mol; CAS 11050-94-5), and Oligomycin C (FW = 775.08 g/mol; CAS 11052-72-5). Others include Oligomycin D (also known as rutamycin; FW = 777.05 g/mol; CAS 1404-59-7), Rutamycin B (isolated from Streptomyces aureofaciens (See also Rutamycin)), and Oligomycin E (FW = 822.07 g/mol; CAS 110231-34-0; isolated from Streptomyces sp. MCI-2225). Primary Mode of Inhibitory Action: The oligomycins inhibit the ATP synthesis activity of the mitochondrial FoF1 ATP synthase, defining the “o” (not 0) in the first subscript. The ATPase activity of the isolated F1 complex is unaffected by oligomycins, unlike the Fo portion. Oligomycin-sensitivity conferring ptrotein (OSCP) interacts with other components in the ATP synthase complex and facilitates oligomycin’s binding to the Fo unit. The Fo complex is, in fact, an integral membrane protein that functions as a proton channel. Other Actions: Oligomycins also inhibit Na+/K+-exchanging ATPases that transport sodium ions from the inside to the outside of animal cells while translocating potassium ions in the reverse direction with the concomitant hydrolysis of ATP. Oligomycin inhibits Na+ translocation in vivo (i.e., the enzyme activity is inhibited by stabilizing the Na+ occlusion but not the K+ occlusion). Other Properties: The oligomycins are slightly soluble in water (e.g., oligomycin A has a solubility of 2 μg per 100 mL at 25°C) and are considerable more soluble in water-miscible solvents such as ethanol, acetone, and glacial acetic acid. Target(s): aldehyde oxidase; ammonia kinase; apyrase, membrane-bound; ATP synthase, or FoF1 ATP synthase; calcidiol 1-monooxygenase; copper-exporting ATPase, partially inhibited; endopeptidase La, weakly inhibited; H+-transporting ATPase, lysosomal; Na+/K+-exchanging ATPase (24- 32); nucleoside triphosphatase; photophosphorylation in Rhodospirillum rubrum; xenobiotic-transporting ATPases.

target

atp synthase

References

1) Antoniel?et al. (2014),?The oligomycin-sensitivity conferring protein of mitochondrial ATP synthase: emerging new roles in mitochondrial pathophysiology;? J. Mol. Sci.,?15?7513 2) Ng et al. (2014),?Essential role of TID1 in maintaining mitochondrial membrane potential homogeneity and mitochondrial DNA integrity;? Mol. Cell Biol.,?34?1427 3) Tettamonti?et al. (2006),?Oligomycin A induces autophagy in the IPLB-LdFB insect cell line;? Cell Tissue Res.,?326?179 4) van Dyke?et al. (1993),?Acidification of rat liver lysosomes:quantification and comparison with endosomes;? Am. J. Physiol.,?265?C901 5) Tanaka?et al. (2013),?Oligomycin, an F1Fo-ATPase inhibitor, protects against ischemic acute kidney injury in male but not in female rats;? J. Pharmacol. Sci.,?123?227

Check Digit Verification of cas no

The CAS Registry Mumber 1404-19-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,4,0 and 4 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1404-19:
(6*1)+(5*4)+(4*0)+(3*4)+(2*1)+(1*9)=49
49 % 10 = 9
So 1404-19-9 is a valid CAS Registry Number.
InChI:InChI=1/C45H74O11/c1-12-34-17-15-13-14-16-27(4)42(51)44(11,53)43(52)32(9)40(50)31(8)39(49)30(7)38(48)26(3)18-21-37(47)54-41-29(6)35(20-19-34)55-45(33(41)10)23-22-25(2)36(56-45)24-28(5)46/h13-15,17-18,21,25-36,38,40-42,46,48,50-51,53H,12,16,19-20,22-24H2,1-11H3/b14-13+,17-15-,21-18+

1404-19-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name Oligomycin

1.2 Other means of identification

Product number -
Other names Oligomycin From Streptomyces Diastatochromogenes

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1404-19-9 SDS

1404-19-9Upstream product

1404-19-9Downstream Products

1404-19-9Related news

Apoptolidins A and C activate AMPK in metabolically sensitive cell types and are mechanistically distinct from OLIGOMYCIN (cas 1404-19-9) A09/08/2019

Apoptolidin A was first isolated as a secondary metabolite of a Nocardiopsis sp. and is the founding member of a family of potential selective cancer cell toxins. We now report the isolation, production and pharmacological characterization of apoptolidins A and C from an alternate actinomycete p...detailed

OLIGOMYCIN (cas 1404-19-9) A and the IPLB-LdFB insect cell line: Actin and mitochondrial responses09/07/2019

Oligomycin A, an inhibitor of mitochondrial ATP synthase, provokes simultaneous and different responses in IPLB-LdFB insect cell line. The oligomycin A treatment causes mitochondrial loss, increase in reactive oxygen species (ROS), destabilization/reorganization of the actin microfilaments and, ...detailed

Research ArticleA comparative study of the single crystal X-ray determination and molecular modelling of the binding of OLIGOMYCIN (cas 1404-19-9) to ATP Synthase09/06/2019

Recently published X-ray structures of three common forms, A, B and C, of oligomycin, including absolute configurations, are investigated to examine their binding to ATP Synthase. The X-ray studies reveal regions with differences in three-dimensional structure and hydrogen bonding propensity bet...detailed

Research paperThe mitochondrial F1FO-ATPase desensitization to OLIGOMYCIN (cas 1404-19-9) by tributyltin is due to thiol oxidation09/04/2019

The antibiotic oligomycin is known to inhibit mitochondrial F-type ATP synthases. The antibiotic inhibits both ATP synthesis and hydrolysis by blocking the H+ translocation through FO which is coupled to the catalytic activity of F1. The amphiphilic organotin tri-n-butyltin (TBT), a known mitoch...detailed

Synthesis and cytotoxicity of OLIGOMYCIN (cas 1404-19-9) A derivatives modified in the side chain09/02/2019

A novel way of chemical modification of the macrolide antibiotic oligomycin A (1) at the side chain was developed. Mesylation of 1 with methane sulfonyl chloride in the presence of 4-dimethylaminopyridine produced 33-O-mesyl oligomycin in 56% yield. Reactions of this intermediate with sodium azi...detailed

ReviewModifiers of the OLIGOMYCIN (cas 1404-19-9) sensitivity of the mitochondrial F1F0-ATPase09/01/2019

The mitochondrial F1F0 complex is highly sensitive to macrolide antibiotics and especially targeted by oligomycins. These compounds bind to the membrane-embedded sector F0 and block proton conductance through the inner membrane, thus inhibiting both ATP synthesis and hydrolysis. Oligomycin sensi...detailed

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1404-19-9